Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 577Triple Negative Breast Neoplasms 125Neoplasm Metastasis 50Breast Neoplasms, Male 28Ovarian Neoplasms 26Neoplasms 26Inflammatory Breast Neoplasms 22Carcinoma, Non-Small-Cell Lung 19Stomach Neoplasms 14Endometrial Neoplasms 11Carcinoma, Ductal, Breast 11Carcinoma, Ovarian Epithelial 10Pancreatic Neoplasms 9Colorectal Neoplasms 9Melanoma 8Lung Neoplasms 8Parkinson Disease 4, Autosomal Dominant Lewy Body 7HER2-positive Breast Cancer 7Squamous Cell Carcinoma of Head and Neck 6Prostatic Neoplasms 6Esophageal Neoplasms 6Carcinoma, Renal Cell 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 4Brain Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Advanced Breast Cancer 4Small Cell Lung Carcinoma 3Sarcoma 3Recurrence 3

Interventions

Paclitaxel 3Doxorubicin 3Cyclophosphamide 3Trastuzumab 2Surgical Procedures, Operative 2Carboplatin 2pertuzumab 1liposomal doxorubicin 1cemiplimab 1atezolizumab 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Lapatinib 1Indocyanine Green 1Anastrozole 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Invasive Breast Cancer × Paclitaxel × Breast × Clear all
NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting
36 enrolled
Breast

Invasive Breast Cancer

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting
650 enrolled
Breast

Invasive Breast Cancer

NCT00486668 2016-06-06

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

NSABP Foundation Inc

Phase 3 Unknown
529 enrolled
Breast

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡